Prochlorperazine Edisylate Injection
Product Images NDC 68083-435

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 68083-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Prochlorperazine-spl-carton-label-10-ml-1s (Prochlorperazine Spl Carton Label 10 mL 1s)

Packaging label for Prochlorperazine Edisylate Injection USP, 50 mg/10 mL (5 mg/mL) multiple-dose vial by Gland Pharma Limited. The label indicates use for deep intramuscular or intravenous injection only, with protection from light. The label includes NDC 68083-436-01 and storage instructions at 20°C to 25°C.*

FDA Label Image

Prochlorperazine-spl-carton-label-2-ml-10s (Prochlorperazine Spl Carton Label 2 mL 10s)

Packaging label for Prochlorperazine Edisylate Injection, USP, 10 mg/2 mL (5 mg/mL) by Gland Pharma Limited. The product is a human prescription drug for intramuscular or intravenous injection. The label states it is for deep intramuscular or intravenous use only, not for subcutaneous use, and contains 10 x 2 mL multiple-dose vials. Additional formulation and storage details are included on the label.*

FDA Label Image

Prochlorperazine-spl-carton-label-2-ml-25s (Prochlorperazine Spl Carton Label 2 mL 25s)

Packaging label for Prochlorperazine Edisylate Injection, USP 10 mg/2 mL (5 mg/mL) by Gland Pharma Limited. The label indicates the product is for deep intramuscular or intravenous use only, not for subcutaneous use, supplied as 25 x 2 mL multiple-dose vials. It includes storage instructions and a barcode for scanning.*

FDA Label Image

Prochlorperazine-spl-structure (Prochlorperazine Spl Structure)

Chemical structure of Prochlorperazine Edisylate, showing the molecular arrangement including aromatic rings, sulfur, nitrogen atoms, and sulfonate groups.*

FDA Label Image

Prochlorperazine-spl-vial-label-10-ml (Prochlorperazine Spl Vial Label 10 mL)

Label for Prochlorperazine Edisylate Injection USP, 5 mg/mL (50 mg/10 mL) in a 10 mL multiple-dose vial. The injection is indicated for deep intramuscular or intravenous use only, not for subcutaneous use. Manufactured by Gland Pharma Limited, Hyderabad, India. The label includes a barcode, lot and expiration date fields, and storage instruction to protect from light.*

FDA Label Image

Prochlorperazine-spl-vial-label-2-ml (Prochlorperazine Spl Vial Label 2 mL)

Label for Prochlorperazine Edisylate Injection USP, 5 mg/mL strength, presented as 10 mg/2 mL per vial. This is a 2 mL multiple-dose vial intended for intramuscular or intravenous use, not for subcutaneous use. The label includes manufacturer information for Gland Pharma Limited, Hyderabad, India, and storage instructions to protect from light. It also notes the product is prescription-only (Rx only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.